SCHEMBL9953816

SCHEMBL9953816

CCN(CC)C(=O)C1C(=O)N(OCc2ccccc2)C(=O)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
USP2 O75604 1/20 0.41
KDM4E B2RXH2 2/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 2/20 0.39
FFAR1 O14842 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TSPO P30536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153981 0.91 MEN1 (0.40) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL9958576 0.86 KMT2A (0.40) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL11787179 0.85 MEN1 (0.47) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL9959279 0.85 KDM4E (0.44) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL9958850 0.83 MEN1 (0.43) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL9952002 0.83 MEN1 (0.45) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL9959297 0.81 HDAC4 (0.49) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL10153642 0.81 KCNA5 (0.42) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL21045029 0.80 MEN1 (0.35) MAPTMEN1KMT2AUSP2KDM4E
SCHEMBL9960452 0.80 KCNA5 (0.46) MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed